Europe — EMA
Letrozolo Alter
GNH USA supplies Letrozolo Alter (Letrozole), an aromatase inhibitor for postmenopausal hormone receptor‑positive breast cancer.
Request sourcing
What is Letrozole?
Letrozole, the active ingredient in Letrozolo Alter, is an aromatase inhibitor presented as an oral tablet for oral use. It treats postmenopausal hormone receptor‑positive breast cancer by lowering estrogen production. GNH USA supplies Letrozolo Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.
What is Letrozole used for?
Letrozole is used in endocrine therapy for hormone‑dependent breast cancer.
Postmenopausal hormone receptor‑positive breast cancer: reduces tumor growth by lowering circulating estrogen levels. Adjuvant therapy: decreases the risk of disease recurrence after surgery. Neoadjuvant therapy: shrinks tumors before surgical removal.
What are the side effects of Letrozole?
Common Side Effects: - Hot flashes - Joint and muscle pain - Fatigue - Nausea - Headache - Increased sweating
Serious or Rare Side Effects: - Severe liver injury - Osteoporotic fractures - Pulmonary embolism - Deep vein thrombosis - Anaphylactic reactions - Significant cholesterol elevation
What precautions apply to Letrozole?
Letrozolo Alter should be used with caution and under medical supervision. - Pregnancy: contraindicated (Category X) – avoid use in pregnant women. - Breastfeeding: not recommended – discontinue if nursing. - Liver function: monitor in patients with hepatic impairment. - Bone health: assess risk of osteoporosis and consider calcium/vitamin D supplementation. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep in the original container, protect from moisture and light.
What does Letrozole interact with?
Letrozolo Alter may interact with several medicines.
Major Interactions (Avoid): - Estrogen replacement therapy: may diminish letrozole efficacy. - Tamoxifen: antagonistic effect on estrogen pathways. - Strong CYP2C19 inhibitors: can increase letrozole plasma concentrations.
Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): may lower letrozole levels. - Anticoagulants (e.g., warfarin): monitor INR and bleeding risk. - Diuretics: may affect electrolyte balance and renal function.
Frequently asked questions
What is Letrozolo Alter used for?+
How does letrozole work in the body?+
What is the usual dose of Letrozolo Alter?+
Is Letrozolo Alter safe during pregnancy or breastfeeding?+
How do I order Letrozolo Alter from GNH USA?+
How does Letrozolo Alter compare with other breast‑cancer therapies?+
What are the storage and handling requirements for Letrozolo Alter?+
How is Letrozolo Alter administered?+
What are the most serious risks associated with Letrozolo Alter?+
Who should not use Letrozolo Alter?+
Product details
Related products

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo